Canada extends GMP to cover active pharmaceutical ingredients

05/14/2013 | In-PharmaTechnologist.com

Canada has issued new regulations, effective in November, that will establish good manufacturing practice requirements for all companies that manufacture, package/label, test or import APIs. Labeling will need to ensure that APIs can be traced from the original manufacturer to the maker of the drug in dosage form.

View Full Article in:

In-PharmaTechnologist.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX